These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 10734164)

  • 21. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
    Kramer TH; Shook JE; Kazmierski W; Ayres EA; Wire WS; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception.
    Sánchez-Blázquez P; Garzón J
    J Pharmacol Exp Ther; 1998 May; 285(2):820-7. PubMed ID: 9580632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice.
    Hosohata Y; Vanderah TW; Burkey TH; Ossipov MH; Kovelowski CJ; Sora I; Uhl GR; Zhang X; Rice KC; Roeske WR; Hruby VJ; Yamamura HI; Lai J; Porreca F
    Eur J Pharmacol; 2000 Feb; 388(3):241-8. PubMed ID: 10675732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse.
    Vanderah TW; Wild KD; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1992 Jul; 262(1):190-7. PubMed ID: 1320682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
    Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
    J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationally designed chimeric peptide of met-enkephalin and FMRFa-[D-Ala2,p-Cl-Phe4]YFa induce multiple opioid receptors mediated antinociception and up-regulate their expression.
    Vats ID; Chaudhary S; Sharma A; Nath M; Pasha S
    Eur J Pharmacol; 2010 Jul; 638(1-3):54-60. PubMed ID: 20385120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
    Qi JA; Mosberg HI; Porreca F
    Life Sci; 1990; 47(11):PL43-7. PubMed ID: 2170791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
    Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
    Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
    Horan PJ; Wild KD; Misicka A; Lipkowski A; Haaseth RC; Hruby VJ; Weber SJ; Davis TP; Yamamura HI; Porreca F
    J Pharmacol Exp Ther; 1993 May; 265(2):896-902. PubMed ID: 8388462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
    Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
    Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.
    Ossipov MH; Kovelowski CJ; Nichols ML; Hruby VJ; Porreca F
    Pain; 1995 Sep; 62(3):287-293. PubMed ID: 8657428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
    Poonyachoti S; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2001 May; 297(2):672-9. PubMed ID: 11303057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective opioid delta agonists elicit antinociceptive supraspinal/spinal synergy in the rat.
    Kovelowski CJ; Bian D; Hruby VJ; Lai J; Ossipov MH; Porreca F
    Brain Res; 1999 Oct; 843(1-2):12-7. PubMed ID: 10528105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
    Shook JE; Pelton JT; Lemcke PK; Porreca F; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse.
    Qi JN; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1990 Aug; 254(2):683-9. PubMed ID: 2166801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.